AstraZeneca announced that beginning on April 1 its contract pharmacy restrictions will apply to three specialty cancer drugs.

AstraZeneca Adds Three Specialty Cancer Drugs to 340B Contract Pharmacy Restrictions

March 6, 2025 Shannon Young, Associate Editor/Senior Writer Views

A U.K.-based drug giant this week moved to add three specialty cancer treatment medications to its list of drugs subject [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!